These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2837247)

  • 21. 4-quinolones and the physiology of DNA gyrase.
    Drlica K; Kreiswirth B
    Adv Pharmacol; 1994; 29A():263-83. PubMed ID: 7826862
    [No Abstract]   [Full Text] [Related]  

  • 22. Topoisomerase II inhibitors influence simian virus 40 chromatin structure in vivo accompanied with inhibition of replication, transcription and changes in DNA supercoiling.
    Waldeck W; Zentgraf H; Rösl F
    Oncology; 1988; 45(2):107-16. PubMed ID: 2832799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regenerating rat liver topoisomerase II: purification of the enzyme and catenation of DNA rings.
    Mirambeau G; Lavenot C; Duguet M
    Adv Exp Med Biol; 1984; 179():423-33. PubMed ID: 6098161
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of the antitumor drug VP16 (etoposide) on the archaebacterial Halobacterium GRB 1.7 kb plasmid in vivo.
    Sioud M; Forterre P; de Recondo AM
    Nucleic Acids Res; 1987 Oct; 15(20):8217-34. PubMed ID: 3671082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of temperature and novobiocin on the expression of calf prochymosin gene and on plasmid copy number in recombinant Escherichia coli.
    Kaprálek F; Tichý PJ; Fábry M; Sedlácek J
    Folia Microbiol (Praha); 1998; 43(1):63-7. PubMed ID: 9569630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novobiocin inhibition of simian virus 40 DNA replication.
    Edenberg HJ
    Nature; 1980 Jul; 286(5772):529-31. PubMed ID: 6250072
    [No Abstract]   [Full Text] [Related]  

  • 27. Coumarin and quinolone action in archaebacteria: evidence for the presence of a DNA gyrase-like enzyme.
    Sioud M; Possot O; Elie C; Sibold L; Forterre P
    J Bacteriol; 1988 Feb; 170(2):946-53. PubMed ID: 2828337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rifampin and rpoB mutations can alter DNA supercoiling in Escherichia coli.
    Drlica K; Franco RJ; Steck TR
    J Bacteriol; 1988 Oct; 170(10):4983-5. PubMed ID: 2844734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The HSP90 and DNA topoisomerase VI inhibitor radicicol also inhibits human type II DNA topoisomerase.
    Gadelle D; Graille M; Forterre P
    Biochem Pharmacol; 2006 Nov; 72(10):1207-16. PubMed ID: 16959221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of action of the des-F(6) quinolone BMS-284756 measured by supercoiling inhibition and cleavable complex assays.
    Wu P; Lawrence LE; Denbleyker KL; Barrett JF
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3660-2. PubMed ID: 11709365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Supercoiling in prokaryotic and eukaryotic DNA: changes in response to topological perturbation of plasmids in E. coli and SV40 in vitro, in nuclei and in CV-1 cells.
    Esposito F; Sinden RR
    Nucleic Acids Res; 1987 Jul; 15(13):5105-24. PubMed ID: 3037487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thioredoxin from Streptomyces aureofaciens controls coiling of plasmid DNA.
    Golubnitchaya-Labudova O; Horecka T; Kapalla M; Perecko D; Kutejova E; Lubec G
    Life Sci; 1998; 62(5):397-412. PubMed ID: 9449230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccinia virus DNA topoisomerase I preferentially removes positive supercoils from DNA.
    Fernandez-Beros ME; Tse-Dinh YC
    FEBS Lett; 1996 Apr; 384(3):265-8. PubMed ID: 8617368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of the minor groove binding agent DAPI (4,6-diamidino-2-phenyl-indole) on DNA-directed enzymes: an attempt to explain inhibition of plasmid expression in Escherichia coli [corrected].
    Parolin C; Montecucco A; Ciarrocchi G; Pedrali-Noy G; Valisena S; Palumbo M; Palu G
    FEMS Microbiol Lett; 1990 Mar; 56(3):341-6. PubMed ID: 2160398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The sensitivity to DNA topoisomerase inhibitors in L5178Y lymphoma strains is not related to a primary defect of DNA topoisomerases.
    Lanza A; Tornaletti S; Stefanini M; Evans HH; Ricanati M; Astaldi Ricotti GC; Pedrini AM
    Carcinogenesis; 1993 Sep; 14(9):1759-63. PubMed ID: 8403196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence that a plasmid from a hyperthermophilic archaebacterium is relaxed at physiological temperatures.
    Charbonnier F; Erauso G; Barbeyron T; Prieur D; Forterre P
    J Bacteriol; 1992 Oct; 174(19):6103-8. PubMed ID: 1328151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of novobiocin on initiation of DNA replication in Bacillus subtilis.
    Ogasawara N; Seiki M; Yoshikawa H
    Nature; 1979 Oct; 281(5733):702-4. PubMed ID: 233136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A plasmid vector with a selectable marker for halophilic archaebacteria.
    Holmes ML; Dyall-Smith ML
    J Bacteriol; 1990 Feb; 172(2):756-61. PubMed ID: 2105303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional analysis of the leading strand replication origin of plasmid pUB110 in Bacillus subtilis.
    Alonso JC; Leonhardt H; Stiege CA
    Nucleic Acids Res; 1988 Oct; 16(19):9127-45. PubMed ID: 2845367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in the linking number of supercoiled DNA accompany growth transitions in Escherichia coli.
    Balke VL; Gralla JD
    J Bacteriol; 1987 Oct; 169(10):4499-506. PubMed ID: 3308843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.